IP 2018 Changes


IP-2018 has been brought out in 4 Volumes incorporating 220 new monographs (Chemical Monographs (170), Herbal Monographs (15), Blood and Blood related products (10), Vaccines and Immunosera for Human use monographs (02), Radiopharmaceutical monographs (03), Biotechnology Derived Therapeutic Products (06), Veterinary monographs (14)), 366 revised monographs and 7 omissions. Salient Features of IP-2018 Keeping in view the essential requirement for harmonization of analytical methods with those accepted internationally, steps have been taken for monitoring drug standards.  General Chemical tests & Thin Layer Chromatography (TLC) for identification of an article have been almost eliminated and more specific infrared, ultraviolet spectrophotometer and HPLC tests have been given emphasis. The concept of relying on published infrared spectra as a basis for identification has been continued.  The use of chromatographic methods has been greatly extended to cope with the need for more specificity in assays and in particular, in assessing the nature and extent of impurities in ingredients and products.  Most of the existing Assays and Related Substances Test methods are upgraded by liquid chromatographic in view to harmonize with other International Pharmacopoeia
Source: http://ipc.nic.in
For more detail visit at : http://ipc.nic.in/showfile.asp?lid=851&EncHid=



© PHARMA WHIZ TERMS AND CONDITIONS PRIVACY POLICY